Form D Explorer
OrbiMed Royalty & Credit Opportunities Access Fund IV LP · CIK 1920989

Report a data issueCitable research briefCompare issuerPrivate research collection

OrbiMed Royalty & Credit Opportunities Access Fund IV LP

CIK 1920989 · Limited Partnership · Inc. DELAWARE · WEST CONSHOHOCKEN, Pennsylvania · Pooled Investment Fund

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
0
Amendments
2
Activity
Mar 19, 2025
through Mar 19, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Both filings have the same date. Their sequence is unknown; directional differences are suppressed.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMar 19, 2025 · D/AMar 19, 2025 · D/ALater minus earlier
Reported offering amount———
Reported amount sold$48,625,000$48,625,000—
Reported investor count———
Reported minimum investment$100,000$100,000—

Earlier SEC source: 0001920989-25-000001 · Later SEC source: 0002018824-25-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Mar 19, 2025

Reported offering amount
—
Reported exemptions
Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
Reported amount sold
$48,625,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Related person name and locality match

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (2)